TSS
NGNE icon

Two Sigma Securities’s Neurogene NGNE Stock Holding History

Two Sigma Securities’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-850
Closed -$11.9K – 3158
2023
Q1 		$11.9K Buy
+850
New +$9.96K ﹤0.01% 2433
2018
Q4 		– Sell
-508
Closed -$30K – 2601
2018
Q3 		$30K Buy
+508
New +$30K ﹤0.01% 2396

Other funds holding NGNE

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
WSL
Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Securities's NGNE Position: Q2 2023 in Review

Two Sigma Securities sold out of Neurogene (NGNE) in Q2 2023, closing a stake of 850 shares — an estimated $11.9K sold.

Two Sigma Securities first reported a position in NGNE in Q3 2018 and held it in 2 quarters. The position peaked at $30K in Q3 2018. 36 funds tracked by Wall St. Rank hold NGNE as of Q2 2023.

  • Two Sigma Securities reported no remaining Neurogene position as of Q2 2023 after selling out during the quarter.
  • Two Sigma Securities sold 850 Neurogene shares in Q2 2023, an estimated $11.9K.
  • Two Sigma Securities first reported a position in Neurogene in Q3 2018 and held it in 2 quarters.
  • Two Sigma Securities's Neurogene position peaked at $30K in Q3 2018.
  • 36 funds tracked by Wall St. Rank held Neurogene as of Q2 2023.

Based on Two Sigma Securities's 13F filing for Q2 2023, filed 14 Aug 2023.